SFI
INFI

Susquehanna Fundamental Investments’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Susquehanna Fundamental Investments’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-49,900
Closed -$59K – 1572
2022
Q3 		$59K Buy
+49,900
New +$53.8K ﹤0.01% 1366
2022
Q1 		$130K Sell
113,808
-15,296
-12% -$18.3K ﹤0.01% 1432
2021
Q4 		$290K Buy
+129,104
New +$324K 0.01% 1128

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Susquehanna Fundamental Investments's INFI Position: Q4 2022 in Review

Susquehanna Fundamental Investments sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 49,900 shares — an estimated $59K sold.

Susquehanna Fundamental Investments first reported a position in INFI in Q4 2021 and held it in 3 quarters. The position peaked at $290K in Q4 2021. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

  • Susquehanna Fundamental Investments reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 49,900 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $59K.
  • Susquehanna Fundamental Investments first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2021 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's Infinity Pharmaceuticals, Inc. position peaked at $290K in Q4 2021.
  • 68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2022, filed 14 Feb 2023.